Allergies know no borders. Neither does collaboration. 🌍 This week, we were honoured to welcome Dr. Motohiro Ebisawa to our headquarters in Denmark. As a world-renowned allergy scientist from Japan, Dr. Ebisawa joined representatives of our medical and scientific teams for an informal, expert-to-expert exchange particularly focusing on food allergy. The purpose of the visit was to exchange perspectives from Japan and Europe to deepen our shared allergy understanding and discuss how scientific insights might translate into better outcomes for people living with these potentially life-threatening allergic conditions across regions. International collaboration is central to our scientific approach at ALK, and dialogues like this help ensure our research reflects the diverse realities of patients and clinicians worldwide. Thank you, Dr. Ebisawa, for the visit and the valuable and inspiring conversations. We look forward to continuing our scientific and collaborative efforts in exploring new avenues to help people living with food allergy worldwide.
ALK’s Post
More Relevant Posts
-
Reposting because this conversation reinforced something I strongly believe: 🌍 Food allergy is the next big frontier in allergy care What stood out for me: - In Japan, walnut allergy is increasing. - There’s a clear near-term gap in available treatment options. - Research momentum is strong—now the work is turning insights into real impact for patients and families. Grateful for the exchange—and for collaborations that keep us grounded in patient reality, not just promising science.
Allergies know no borders. Neither does collaboration. 🌍 This week, we were honoured to welcome Dr. Motohiro Ebisawa to our headquarters in Denmark. As a world-renowned allergy scientist from Japan, Dr. Ebisawa joined representatives of our medical and scientific teams for an informal, expert-to-expert exchange particularly focusing on food allergy. The purpose of the visit was to exchange perspectives from Japan and Europe to deepen our shared allergy understanding and discuss how scientific insights might translate into better outcomes for people living with these potentially life-threatening allergic conditions across regions. International collaboration is central to our scientific approach at ALK, and dialogues like this help ensure our research reflects the diverse realities of patients and clinicians worldwide. Thank you, Dr. Ebisawa, for the visit and the valuable and inspiring conversations. We look forward to continuing our scientific and collaborative efforts in exploring new avenues to help people living with food allergy worldwide.
-
-
“Today, 8.2 million Australians – almost one in three of us – are affected. When I look back, the growth is striking. In 2007, around 4.1 million Australians were living with allergic disease. That number has now doubled. It’s clear that allergy has become one of Australia’s fastest growing chronic conditions.” Murdoch Children’s Research Institute Prof Kirsten Perrett revealed to the Herald Sun how allergies had become one of the top health concerns for Australian children, touching almost every family, school and healthcare service. Professor Perrett is also Director of the National Allergy Centre of Excellence (NACE), Australia’s peak allergy research body, and the Centre for Food Allergy Research (CFAR), a national collaboration of food allergy experts. Both centres are hosted at MCRI to accelerate research, reduce the burden of allergic disease and ultimately save lives. A major step forward was taken by her team in 2024 with the introduction of the ADAPT Oral Immunotherapy Program, when NACE partnered with 10 public hospitals across Australia to take peanut allergy treatment out of clinical trials and into routine care. Read more: https://lnkd.in/gsARaiKM #ChildHealth #Allergy #FoodAllergies National Allergy Council , Australasian Society of Clinical Immunology and Allergy, Allergy & Anaphylaxis Australia
-
-
A really important focus in order to highlight and build awareness around this crucial topic. Chat with us about our comprehensive and easy to use PPDS labelling solutions in order to easily achieve and maintain compliance.
Today marks a historic moment, with the launch of the UK’s first National Allergy Strategy in Westminster by The National Allergy Strategy Group. Our co-founder Nadim Ednan-Laperouse OBE alongside Adam Fox OBE joined #GoodMorningBritain today to talk about why the UK’s first National Allergy Strategy matters and why action can’t wait. This strategy is the result of over two decades of campaigning, and an unprecedented coalition of clinicians, professionals, allergy charities including Natasha’s Foundation and the wider allergy community, coming together to set out what good should look like for #allergy care in the UK. At Natasha’s Foundation, our focus is food allergy, but food allergy does not exist in isolation. Allergic disease affects millions of people in the UK. It is complex, wide-reaching, and for too long allergy has been under-recognised and under-resourced in this country. Too often, progress has only come after tragedy and we cannot continue to wait for catastrophic events to happen and then rely on bereaved families to drive change. We need a system that is proactive, not reactive, one that prevents harm before it happens. This strategy sets out that vision. "This is not about spending money on new drugs or opening more hospitals, this is a conversation we should be having around a table to move things forward. We want to discuss this strategy with ministers, they just need to be willing to meet the very people that put them in office". - Nadim Ednan-Laperouse OBE We will continue to lead and push for change where it matters most, making food safer, improving understanding, raising allergy awareness and ensuring that no family has to experience avoidable harm. We must get it right. #AllergyAwarenessWeek #NationalAllergyStrategy #FoodAllergy #MakeAllergiesHistory Benedict Blythe Foundation Allergy UK Anaphylaxis UK BSACI Allergy Adam Fox OBE
-
It’s good to see allergen management getting the attention it deserves, following the launch of the UK’s first National Allergy Strategy. This video is a powerful reminder of why it matters. For people living with allergies, eating out should feel safe, not uncertain. That’s where clear, consistent standards come in. Safe to Trade gives people confidence through visible reassurance - helping them choose places where allergy safety is being taken seriously, every day. Because when it comes to allergens, consistency isn’t optional - it’s essential. Find out more: https://lnkd.in/eQvGyW-y #AllergyAwarenessWeek #AllergenManagement #FoodSafety #Hospitality #SafeToTrade
Today marks a historic moment, with the launch of the UK’s first National Allergy Strategy in Westminster by The National Allergy Strategy Group. Our co-founder Nadim Ednan-Laperouse OBE alongside Adam Fox OBE joined #GoodMorningBritain today to talk about why the UK’s first National Allergy Strategy matters and why action can’t wait. This strategy is the result of over two decades of campaigning, and an unprecedented coalition of clinicians, professionals, allergy charities including Natasha’s Foundation and the wider allergy community, coming together to set out what good should look like for #allergy care in the UK. At Natasha’s Foundation, our focus is food allergy, but food allergy does not exist in isolation. Allergic disease affects millions of people in the UK. It is complex, wide-reaching, and for too long allergy has been under-recognised and under-resourced in this country. Too often, progress has only come after tragedy and we cannot continue to wait for catastrophic events to happen and then rely on bereaved families to drive change. We need a system that is proactive, not reactive, one that prevents harm before it happens. This strategy sets out that vision. "This is not about spending money on new drugs or opening more hospitals, this is a conversation we should be having around a table to move things forward. We want to discuss this strategy with ministers, they just need to be willing to meet the very people that put them in office". - Nadim Ednan-Laperouse OBE We will continue to lead and push for change where it matters most, making food safer, improving understanding, raising allergy awareness and ensuring that no family has to experience avoidable harm. We must get it right. #AllergyAwarenessWeek #NationalAllergyStrategy #FoodAllergy #MakeAllergiesHistory Benedict Blythe Foundation Allergy UK Anaphylaxis UK BSACI Allergy Adam Fox OBE
-
Planglow Allergy awareness is still so important especially in schools, understanding and having effective systems in place, can make a huge difference to keeping students safe and included.💛
Today marks a historic moment, with the launch of the UK’s first National Allergy Strategy in Westminster by The National Allergy Strategy Group. Our co-founder Nadim Ednan-Laperouse OBE alongside Adam Fox OBE joined #GoodMorningBritain today to talk about why the UK’s first National Allergy Strategy matters and why action can’t wait. This strategy is the result of over two decades of campaigning, and an unprecedented coalition of clinicians, professionals, allergy charities including Natasha’s Foundation and the wider allergy community, coming together to set out what good should look like for #allergy care in the UK. At Natasha’s Foundation, our focus is food allergy, but food allergy does not exist in isolation. Allergic disease affects millions of people in the UK. It is complex, wide-reaching, and for too long allergy has been under-recognised and under-resourced in this country. Too often, progress has only come after tragedy and we cannot continue to wait for catastrophic events to happen and then rely on bereaved families to drive change. We need a system that is proactive, not reactive, one that prevents harm before it happens. This strategy sets out that vision. "This is not about spending money on new drugs or opening more hospitals, this is a conversation we should be having around a table to move things forward. We want to discuss this strategy with ministers, they just need to be willing to meet the very people that put them in office". - Nadim Ednan-Laperouse OBE We will continue to lead and push for change where it matters most, making food safer, improving understanding, raising allergy awareness and ensuring that no family has to experience avoidable harm. We must get it right. #AllergyAwarenessWeek #NationalAllergyStrategy #FoodAllergy #MakeAllergiesHistory Benedict Blythe Foundation Allergy UK Anaphylaxis UK BSACI Allergy Adam Fox OBE
-
In just one week, Reacta Healthcare’s Innovation team will travel to Beijing and Hong Kong to engage with food allergy clinical trial specialists across the region. The visit reflects our ongoing commitment to collaboration, shared expertise and supporting global progress in allergy clinical research. From hosting a symposium at the EAACI Allergy School in Beijing to attending the Asia Summit on Global Health in Hong Kong, the team looks forward to contributing to important discussions on food allergy research, oral food challenge practice and international health innovation.
-
Our understanding about allergy more recently is that the way that many factors like diet and environment influence our gut bacteria, what we call our microbiome, seem to be increasing our tendency to develop allergic responses to the outside world. And as a result, we've got this huge amount of allergy in the UK. And frustratingly, and certainly compared to other developed healthcare economies, the provision of specialist services, and in fact even knowledge amongst GPs, for example, at managing allergy is not as good as it could be. Why the National Allergy Strategy matters: - 39% of children, 30% of adults affected; over one-quarter of the UK population - Most GPs have no allergy training despite 1 in 3 patients having allergic conditions - Multiple reports from the Royal College of Physicians and APPG for Allergy highlight service gaps - Repeated tragedies exposing system failures in schools, restaurants and healthcare settings - Postcode lottery of access; poorer outcomes in deprived and ethnic minority communities Without national coordination, allergy remains fragmented across multiple sectors with no clear ownership, leading to policy gaps, inconsistent protection and preventable harm. Grateful to talk about this on BBC Breakfast yesterday.
-
On a chilly January day this year, our team were welcomed to Adam Fox OBE's new (ish) Allergy Centre of Excellence (ACE) in London. The realisation of a long-held dream of Adam's, along with colleagues Professor Gideon Lack and George Du Toit, ACE aims to provide patient centred and responsive care, backed up by the highest safety standards which is supported by the most experienced clinicians. ACE offers the latest treatments of personalised desensitisation programmes for children. And NOW, we are so delighted to see the launch of the National Allergy Strategy Group, also a longtime in the pipeline and not before time! Congratulations to everyone working so incredibly, tirelessly, even sleeplessly hard on these initiatives that will, without doubt, make a safer environment for all with allergies & food hypersensitivities. The Natasha Allergy Research Foundation Allergy UK Anaphylaxis UK The British Society for Allergy and Clinical Immunology https://lnkd.in/eQmkutxv
Professor of Paediatric Allergy at Guy’s & St Thomas’ Hospitals, Chair of National Allergy Strategy Group, Past-President of British Society for Allergy & Clinical Immunology
Today marks the launch of the UK’s first National Allergy Strategy in Westminster by the National Allergy Strategy Group (an alliance of allergy professional organisations and patient charities, with further launches planned in the devolved nations). I was very pleased to be on Good Morning Britain this morning to talk about this with Nadim Ednan-Laperouse OBE. We have to move away from this approach that we're waiting for catastrophic events to happen and then relying on the advocacy of parents to make change happen. What this strategy is about, it's about getting in front of that. It's about being proactive. This is a plan that the whole allergy community has really come together to put forward to say this is what good looks like for the allergy community. This is the change that we need. And it's not just about food allergy or food labelling. It's about medication allergies. It's about asthma, eczema, the whole range of allergic disease that affects a third of people in the UK. The National Allergy Strategy is the result of over two decades of campaigning from clinicians, charities and people living with allergic disease. The British Society for Allergy and Clinical Immunology, The Natasha Allergy Research Foundation, Allergy UK Anaphylaxis UK #Unitedwewilltackleallergy #allergyawarenessweek
-
Important and timely message. Across the UK, allergic disease is still too often under-recognised, and delays in diagnosis can have real consequences for quality of life and safety. The focus on earlier recognition and access to appropriate care feels especially critical, particularly given how interconnected conditions like asthma, eczema, and food allergy are. Great to see Allergy UK leading this conversation through Allergy Awareness Week and linking it to the momentum of the National Allergy Strategy. Hopefully this helps drive both public awareness and system-level change.
Allergy UK Today we’re launching Allergy Awareness Week 2026 with a clear message: Diagnosis matters. Millions of people across the UK are living with allergy symptoms without a diagnosis — often for years. Through Allergy UK’s I Wish I Knew campaign, we’re encouraging people to recognise the signs of allergic disease earlier and seek the right support. Earlier diagnosis can be life‑changing, improving quality of life and reducing preventable risks. Allergy remains widely misunderstood and under‑recognised. Hospital admissions for anaphylaxis continue to rise, and conditions such as eczema, asthma and food allergy are closely linked. Yet fewer than 10% of children with food allergy are seen in a specialist clinic, leaving many families navigating uncertainty alone. Time and again we hear: “I wish I knew sooner.” This campaign is about ensuring more people have that knowledge earlier, so they can take control of their health. This year also marks a major milestone with the launch of the UK’s first National Allergy Strategy, setting out a long‑term vision for improved care, awareness and safer everyday environments. I hope Allergy Awareness Week helps start a national conversation, so more people recognise the signs of allergy, access support sooner and live safer, healthier lives. 🔗 https://lnkd.in/eHdmS3FM #AllergyAwarenessWeek #DiagnosisMatters #AllergyUK #PatientVoice #PublicHealth #NationalAllergyStrategy
-
A great article about the exciting developments in the field of food allergy treatment with a key focus on patient need
This week is Food Allergy Awareness Week (#FAAW) in the USA - an important moment to reflect on the progress being made for millions of patients and families living with food allergy. At Aravax, we are encouraged by the convergence of scientific advances, regulatory momentum, and commercial investment that is reshaping the future of food allergy therapeutics. In this thought piece, our CEO Pascal Hickey shares perspectives on the recent developments driving the field forward — and why we believe food allergy treatments are entering a new phase focused not just on short-term protection, but also lasting disease modification. 📖 Read the article HERE https://lnkd.in/eHT_hDjG We are proud to be contributing to this progress through our next-generation peptide-based immunotherapies, designed to retrain the immune system while avoiding treatment-induced allergic reactions. Our lead product, #PVX108, is being developed as a once-monthly therapy for peanut allergy and our Phase II trial in the USA and Australia is expected to read out later this year. Follow us to stay updated on our progress: www.aravax.bio #FoodAllergy #PeanutAllergy #Immunotherapy #Biotech #DrugDevelopment #Innovation
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development
Congratulations Dr Ebisawa 👏👏👏